Research programme: antifungals - Thallion PharmaceuticalsAlternative Names: Antifungals research programme - Thallion Pharmaceuticals; ECO 02301 class; ECO-02301; ECO-14401; ECO-4401
Latest Information Update: 26 Aug 2009
At a glance
- Originator Ecopia BioSciences
- Class Macrolides; Polyenes
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 26 Aug 2009 No development reported - Preclinical for Mycoses in Canada (unspecified route)
- 30 Jan 2003 Preclinical trials in Mycoses in Canada (unspecified route)